Real-World Data on the Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced/Metastatic Breast Cancer

Αntria Savvidou, Anastasia Constantinidou, Lefteris Zacharia, Kyriaki Michailidou, Μaria Zanti, Stavroula Kitiri, Yiola Marcou, Ifigenia Konstantinou, Eleni Kakouri, Myria Galazi, Christos Petrou

Open source

DOI
10.14740/wjon2750
Published
2026-06
Container
World Journal of Oncology
Publisher
Elmer Press, Inc.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.14740/wjon2750,
  title = {Real-World Data on the Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced/Metastatic Breast Cancer},
  author = {Αntria Savvidou and Anastasia Constantinidou and Lefteris Zacharia and Kyriaki Michailidou and Μaria Zanti and Stavroula Kitiri and Yiola Marcou and Ifigenia Konstantinou and Eleni Kakouri and Myria Galazi and Christos Petrou},
  year = {2026},
  journal = {World Journal of Oncology},
  doi = {10.14740/wjon2750},
  url = {https://doi.org/10.14740/wjon2750}
}

RIS

TY  - JOUR
TI  - Real-World Data on the Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced/Metastatic Breast Cancer
AU  - Αntria Savvidou
AU  - Anastasia Constantinidou
AU  - Lefteris Zacharia
AU  - Kyriaki Michailidou
AU  - Μaria Zanti
AU  - Stavroula Kitiri
AU  - Yiola Marcou
AU  - Ifigenia Konstantinou
AU  - Eleni Kakouri
AU  - Myria Galazi
AU  - Christos Petrou
PY  - 2026
JO  - World Journal of Oncology
DO  - 10.14740/wjon2750
UR  - https://doi.org/10.14740/wjon2750
ER  - 

APA

Savvidou, Α., Constantinidou, A., Zacharia, L., Michailidou, K., Zanti, Μ., Kitiri, S., Marcou, Y., Konstantinou, I., Kakouri, E., Galazi, M., & Petrou, C. (2026). Real-World Data on the Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced/Metastatic Breast Cancer. World Journal of Oncology. https://doi.org/10.14740/wjon2750

Source records